1. Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation
   Hannah R. Moorman et al, 2020, Cancers CrossRef
2. Integrin β3 and CD44 levels determine the effects of the OPN-a splicing variant on lung cancer cell growth
   Shih-Jung Sun et al, 2016, Oncotarget CrossRef
3. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer
   Chengcheng Hao et al, 2021, Cells CrossRef
4. Early Biomarkers in Breast Cancer
   Ruchika Kaul-Ghanekar et al, 2015, Noninvasive Molecular Markers in Gynecologic Cancers CrossRef
5. Phase Composition of Samarium Niobate and Tantalate Thin Films Prepared by Sol-Gel Method
   H. Bruncková et al, 2017, Powder Metallurgy Progress CrossRef
6. S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma
   Lu-Nan Qi et al, 2021, Hepatology International CrossRef
7. Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior
   Luciana Bueno Ferreira et al, 2016, Oncotarget CrossRef
8. The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers
   Tengteng Wei et al, 2020, Frontiers in Molecular Biosciences CrossRef
9. Overexpression of Secreted Phosphoprotein 1 (SPP1) predicts poor survival in HPV positive cervical cancer
   Pasumarthi Deepti et al, 2022, Gene CrossRef
10. Impact of Alternative Splicing Variants on Liver Cancer Biology
    Jose J. G. Marin et al, 2021, Cancers CrossRef
11. S100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion
    Hongfei Jiang et al, 2016, Cancer Investigation CrossRef
12. Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
    Jules Lin et al, 2015, Oncotarget CrossRef
13. Enhanced Glucose Uptake in Phenylbutyric Acid-Treated 3T3-L1 Adipocytes
    H. Fakhoury et al, 2018, Cell and Tissue Biology CrossRef